Joanna Wasilewska

The outcomes of ponatinib therapy in patients with chronic myeloid leukemia resistant or intolerant to previous tyrosine kinase inhibitors, treated in Poland within the donation program

O. Grzybowska-Izydorczyk, J. Góra‐Tybor, E. Patkowska, 2021, Clinical Lymphoma Myeloma and Leukemia.